West Pharmaceutical Services, Inc.
WST
주식 순위
#880
West Pharmaceutical Services, Inc. (WST) specializes in the development,... West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
주가
$389.10
마지막 동기화: 2026-10-20
시가총액
$27.38B
변동 (1일)
1.30%
변동 (1년)
39.27%
국가
US
거래 West Pharmaceutical Services, Inc. (WST)
카테고리
Healthcare
West Pharmaceutical Services, Inc. (WST)의 매출
Jun 2026 기준 매출 TTM: $3.33B
West Pharmaceutical Services, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $3.33B입니다. 2024년에 회사는 $2.89B의 수익을 올렸으며 이는 2023년의 $2.95B 대비 감소입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
West Pharmaceutical Services, Inc.의 수익 기록 (2000 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $3.33B | 8.21% |
| 2025 | $3.07B | 6.27% |
| 2024 | $2.89B | -1.98% |
| 2023 | $2.95B | 2.27% |
| 2022 | $2.89B | 1.94% |
| 2021 | $2.83B | 31.86% |
| 2020 | $2.15B | 16.44% |
| 2019 | $1.84B | 7.31% |
| 2018 | $1.72B | 7.36% |
| 2017 | $1.60B | 6.04% |
| 2016 | $1.51B | 7.95% |
| 2015 | $1.40B | -1.67% |
| 2014 | $1.42B | 3.91% |
| 2013 | $1.37B | 8.04% |
| 2012 | $1.27B | 6.19% |
| 2011 | $1.19B | 7.96% |
| 2010 | $1.10B | 4.64% |
| 2009 | $1.06B | 0.44% |
| 2008 | $1.05B | 3.04% |
| 2007 | $1.02B | 11.69% |
| 2006 | $913.30M | 30.53% |
| 2005 | $699.70M | 29.19% |
| 2004 | $541.60M | 10.37% |
| 2003 | $490.70M | 16.92% |
| 2002 | $419.70M | 5.74% |
| 2001 | $396.90M | -7.72% |
| 2000 | $430.10M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $11.03B | 231.71% |
US
|
|
| $34.74B | 944.24% |
FR
|
|
| - | - |
JP
|
|
| $20.84B | 526.45% |
US
|
|
| - | - |
CH
|
